Boehringer Ingelheim and Lilly expand heart failure programme for empagliflozin with new exercise capacity trials
「Symptoms of heart failure can have a profound effect on quality of life, with more than three quarters of people with heart failure finding it difficult to carry out routine activities,」 said Je......
